The increasing costs and complexity of R&D in the pharmaceutical industry have necessitated the adoption of strategic ...

Azurity Pharmaceuticals has acquired Covis Group from existing investors, making the latter a wholly owned subsidiary.

Despite a rocky start for many drugmakers at the start of last year, 2024’s fourth quarter saw just two of the top 25 global ...

Driven by innovation, research, and a deep commitment to social responsibility, Pharmalat has grown from a small, family-run ...

Seeking more efficient drug development, pharmaceutical giants and startups are encouraging AI fluency and in some cases ...

Staff and funding cuts to the NIH, FDA and USAID could have downstream implications for R&D in the pharma industry, experts ...

In November 2024, Zealand Pharma presented detailed results from the Phase 1b 16-week multiple ascending dose (MAD) trial at ...

Roche Holding said it would pay Danish biotechnology research company Zealand Pharma up to $5.3 billion under an agreement to ...

Sun Pharma and Zydus Pharmaceuticals are recalling products in the US market due to manufacturing issues, according to the ...

The National Agency for Food and Drug Administration and Control, NAFDAC, has gone digital in its efforts to rid the country ...